Novel biomarkers and uses thereof

Disclosed herein are novel biomarkers for identifying patients, with cancer, likely to benefit from treatment with an anti-CD25 agent. Also disclosed are methods using said biomarkers for making a treatment decision - or monitoring treatment with an anti-CD25 agent as well as methods of treating a p...

Full description

Saved in:
Bibliographic Details
Main Authors KOLBEN, THERESA, SCHMICH, FABIAN, KARANIKAS, VAIOS, CANNARILE, MICHAEL, RUETTINGER, DOMINIK, GOMES, BRUNO
Format Patent
LanguageChinese
English
Published 16.01.2023
Subjects
CHEMISTRY
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
TESTING
Online AccessGet full text

Cover

More Information
Summary:Disclosed herein are novel biomarkers for identifying patients, with cancer, likely to benefit from treatment with an anti-CD25 agent. Also disclosed are methods using said biomarkers for making a treatment decision - or monitoring treatment with an anti-CD25 agent as well as methods of treating a patient, with cancer, comprising administering an anti-CD25 agent based on prior use of the present biomarkers.
Bibliography:Application Number: TW202211107231